Heparin skeleton synthase and its mutants and application
A heparin skeleton synthase originates from Neisseria animaloris , with an amino acid sequence as shown in SEQ ID NO.2 and a nucleotide sequence of the coding gene as shown in SEQ ID NO.1. Its recombinant expression level is 6.8 times that of the existing heparin skeleton synthase KfiA from Escherichia coli K5, and total enzyme activity per fermentation liquor is 5.22 times that of the heparin skeleton synthase KfiA. The heparin skeleton synthase mutants obtained through site-directed mutagenesis of the sites No. 16, No. 25, No. 30, No. 111, No. 165, and No. 172 in the amino acid sequence of the said heparin skeleton synthase all have high expression levels.
1. A mutant heparin skeleton synthase (NaGlcNAc-T) is obtained from a wild-type NaGlcNAc-T, wherein the mutant NaGlcNAc-T is selected from the group consisting of a mutant heparin skeleton synthase having C16L mutation and comprises the amino acid sequence of SEQ ID NO: 4, a mutant heparin skeleton synthase having N25P mutation and comprises the amino acid sequence of SEQ ID NO: 6, a mutant heparin skeleton synthase having I30L mutation and comprises the amino acid sequence of SEQ ID NO: 8, a mutant heparin skeleton synthase having I111S mutation and comprises the amino acid sequence of SEQ ID NO: 10, a mutant heparin skeleton synthase having S165K mutation and comprises the amino acid sequence of SEQ ID NO: 12, a mutant heparin skeleton synthase having S172A mutation and comprises the amino acid sequence of SEQ ID NO: 14.
2. The mutant heparin skeleton synthase, NaGlcNAc-T, according to claim 1 , wherein the mutant NaGlcNAc-T is the mutant heparin skeleton synthase having C16L mutation and comprises the amino acid sequence of SEQ ID NO: 4.
3. The mutant heparin skeleton synthase, NaGlcNAc-T, according to claim 1 , wherein the mutant NaGlcNAc-T is the mutant heparin skeleton synthase having mutation N25P and comprises the amino acid sequence of SEQ ID NO: 6.
4. The mutant heparin skeleton synthase, NaGlcNAc-T, according to claim 1 , wherein the mutant NaGlcNAc-T is the mutant heparin skeleton synthase having I30L mutation and comprises the amino acid sequence of SEQ ID NO: 8.
5. The mutant heparin skeleton synthase, NaGlcNAc-T, according to claim 1 , wherein the mutant NaGlcNAc-T is the mutant heparin skeleton synthase having I111S mutation and comprises the amino acid sequence of SEQ ID NO: 10.
6. The mutant heparin skeleton synthase, NaGlcNAc-T, according to claim 1 , wherein the mutant NaGlcNAc-T is the mutant heparin skeleton synthase having S165K mutation and comprises the amino acid sequence of SEQ ID NO: 12.
7. The mutant heparin skeleton synthase, NaGlcNAc-T, according to claim 1 , wherein the mutant NaGlcNAc-T is the mutant heparin skeleton synthase having S172A mutation and comprises the amino acid sequence of SEQ ID NO: 14.